No Data
Emerging Markets outlook: After the meetings of the central banks in Japan and the United States, attention will shift towards the growth market.
The individual stocks with specific materials are attracting a lot of interest, and this week's Emerging Markets have risen. The performance during the same period was +0.97% for the Nikkei average, while the Growth Market Index was +1.63% and the Growth Market 250 Index was +1.70%, indicating that the Emerging Markets were relatively strong. At the beginning of the week, due to the upcoming calculation of the December Futures and Single Option special settlement price (SQ value) at the weekend and the rise in US stocks, Large Cap stocks showed strength, pulling the Emerging Markets along with them. As we approached the weekend, the majors...
Atrae's Investee Company Eucalia Debuts on Tokyo Stock Exchange
The Nikkei Average started with a 477 yen increase, and Recruit HD, Ryohin Keikaku, etc. rose
[Nikkei Stock Average, TOPIX (table)] Nikkei Average; 39849.97; +477.74TOPIX; 2775.82; +26.51 [Close Overview] The Nikkei Average on the 12th rose 477.74 yen to 39849.97 yen for 4 days and began trading. The US stock market the day before, on the 11th, was mixed. The Dow average closed at 44148.56 dollars, which was 99.27 dollars lower, and the NASDAQ closed at 20034.90, which was 347.65 points higher. November Consumer Price Index (
Yukaria --- initial price: 975 yen (public price: 1060 yen)
The initial price of Yukaria ＜286A＞ was 975 yen, 8.0% below the public price. The trading volume at the time of initial price formation was 2.02 million6800 shares.
Yukaria --- sales momentum, newly listed on the Tokyo Stock Exchange growth market today
Today, Yukaria (286A) was listed on the Tokyo Stock Exchange Growth Market. Currently, at the public price of 1060 yen, the purchase price is about 0.43 million shares, the sale is about 2.18 million shares, and about 1.75 million shares by deduction.
Yukaria --- Initial Financial Estimates Consensus
Today, Yukaria <286A>, which provides management support for medical corporations, operates and introduces facilities for the elderly, and manufactures and sells contact lenses, will be listed on the Tokyo Stock Exchange Growth Market. Against a public offering price of 1,060 yen, the initial price forecast consensus in the market is observed to be around 1,700 yen.